跳至主要内容
临床试验/IRCT20190109042305N1
IRCT20190109042305N1招募中3 期

The effect of nebulized Furosemide in Chronic Obstructive Pulmonary Disease exacerbation patients.

Sari University of Medical Sciences0 个研究点目标入组 47 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
47

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • COPD exacerbation patients
  • FEV1/FVC less than 70%
  • No need for ventilator

排除标准

  • FEV1 Increase greater than 200 cc or 12% after salbutamol administration in spirometry
  • The history of infectious diseases such as tuberculosis, recent respiratory infections, bronchiectasis and acute or chronic diarrhea
  • Probability of malignancy based on examination
  • Rheumatic arthritis, degenerative joint disease, vasculitis

研究者

发起方
Sari University of Medical Sciences

相似试验